| dc.contributor.author | C. Uday Bhanu | |
| dc.date.accessioned | 2026-02-26T07:21:53Z | |
| dc.date.available | 2026-02-26T07:21:53Z | |
| dc.date.issued | 2014 | |
| dc.identifier.uri | https://digitallibrary.bldedu.ac.in/xmlui/handle/123456789/6078 | |
| dc.description.abstract | One of the most overlooked of all serious complications of diabetes is cardiovascular autonomic neuropathy (CAN), which encompasses damage to the autonomic nerve fibers that innervate the heart and blood vessels, and causes denervation resulting in abnormalities in heart rate control and vascular dynamics.The present report discusses the clinical manifestations resting tachycardia, orthostasis, exercise intolerance, dizziness in the presence of CAN. It also demonstrates that autonomic dysfunction can affect daily activities of individuals with diabetes and may invoke potentially life-threatening outcomes. Advances in technology, built on decades of research and clinical testing, now make it possible to objectively identify early stages of CAN with the use of careful measurement of autonomic function and to provide therapeutic choices that are based on symptom control and that might abrogate the underlying disord | en_US |
| dc.language.iso | en | en_US |
| dc.publisher | BLDE (Deemed to be university) | en_US |
| dc.subject | Parasympathetic,Sympathetic,Cardiovascular autonomic function tests,denervation,HbA1c. | en_US |
| dc.title | PREVELANCE OF CARDIAC AUTONOMIC NEUROPATHY IN TYPE II DIABETES MELLITUS | en_US |
| dc.type | Other | en_US |